课题基金 / 基金详情

Rational, Computational Design of Novel anti-AIDS Drugs

Rational, Computational Design of Novel anti-AIDS Drugs
新型抗艾滋病药物的合理计算设计
批准号:
6653698
负责人:
RICHARD H SMITH
金额:
$13.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-06-15 至 2006-05-31

项目摘要

项目成果

RICHARD H SMITH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal seeks to address the problem of drug resistance to nonnucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs) through the refinement and extension of our computational methodology for predicting drug activity prior to synthesis and clinical testing. The goal is to build upon our past accomplishments in the use of Monte Carlo (MC) simulations coupled with a linear response (LR) method to predict activity against variant forms of RT (Y181C, Y188C, L1001, V106A, K101 E, K103N, and possible double mutants) that are resistant to all current anti-AIDS drugs. Hybrid quantum mechanics/molecular mechanics (QM/MM) refinements to the MC methodology and routines for protein backbone approximation will be incorporated to improve the accuracy of predictions. A new, rapid preliminary screening technique employing a combinatorial computational approach will be used to evaluate candidate structures prior to full computational evaluation. The proposed changes in methodology are anticipated to significantly improve the treatment of both the inhibitor and the protein backbone, problems of paramount importance if computational methods are to succeed in accurately predicting host-guest interactions in novel systems. The overall goal is to enhance the speed and accuracy of designing effective inhibitors of resistant forms of RT. The new methodology will be employed in the design of new members of a novel class of NNRTI's, BPBrs, developed in conjunction with collaborators at NCI-Frederick. Newly proposed BPBI analogs showing good predicted activity against variant forms of RT will be synthesized and tested for broad spectrum activity. While a specific and extremely important objective of the proposal is to discover new inhibitors targeted toward NNIRT resistant viruses found in AIDS patients, the general computational methodology developed herein has broad applications to the accurate description of binding in all host-guest interactions that involve proteins and organic molecules.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
HIV-1 reverse transcriptase variants: molecular modeling of Y181C, V106A, L100I, and K103N mutations with nonnucleoside inhibitors using Monte Carlo simulations in combination with a linear response method.
HIV-1 逆转录酶变体:使用蒙特卡罗模拟结合线性响应方法,使用非核苷抑制剂对 Y181C、V106A、L100I 和 K103N 突变进行分子建模。
DOI: 10.3109/10559610390484203
发表时间: 2003
期刊: Drug design and discovery
影响因子: --
作者: [Smith,MarilynBKroeger, Ruby,Sandra, Horouzhenko,Stanislav, Buckingham,Bryan, Richardson,Julia, Puleri,Ina, Potts,Emily, Jorgensen,WilliamL, Arnold,Edward, Zhang,Wanyi, Hughes,StephenH, Michejda,ChristopherJ, SmithJr,RichardH]
通讯作者: SmithJr,RichardH
Integrated Fiber Optic Sensor for DNA Hydridization
  • 批准号:
    6655638
  • 项目类别:
  • 资助金额:
    $29.74万
  • 财政年份:
    2000
  • 负责人:
    RICHARD H SMITH
  • 依托单位:
INTEGRATED FIBER OPTIC SENSOR FOR DNA HYBRIDIZATION
  • 批准号:
    6073649
  • 项目类别:
  • 资助金额:
    $10.66万
  • 财政年份:
    2000
  • 负责人:
    RICHARD H SMITH
  • 依托单位:
Integrated Fiber Optic Sensor for DNA Hydridization
  • 批准号:
    6551352
  • 项目类别:
  • 资助金额:
    $44.04万
  • 财政年份:
    2000
  • 负责人:
    RICHARD H SMITH
  • 依托单位:
BIOSENSOR STUDIES OF ESTROGENIC COMPOUNDS WITH HER-A & B
  • 批准号:
    6015289
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    1999
  • 负责人:
    RICHARD H SMITH
  • 依托单位:
海外基金